This fact sheet describes the efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and distribution of MenAfriVac®, the vaccine that has virtually eliminated meningitis A wherever it has been introduced.

This training module, developed by PATH, was developed to provide a basic structure and essential content for a training session to educate vaccinators about hepatitis B, equip them with the skills to safely administer the hepatitis B vaccine, and prepare them to decrease drop-out rates and increase coverage through communication with parents, caretakers and local leaders.

This training module, developed by PATH, was developed to provide a basic structure and essential content for a training session to educate vaccinators about hepatitis B, equip them with the skills to safely administer the hepatitis B vaccine, and prepare them to decrease drop-out rates and increase coverage through communication with parents, caretakers and local leaders.

This training module, developed by PATH, was developed to provide a basic structure and essential content for a training session to educate vaccinators about hepatitis B, equip them with the skills to safely administer the hepatitis B vaccine, and prepare them to decrease drop-out rates and increase coverage through communication with parents, caretakers and local leaders.

This training module, developed by PATH, was developed to provide a basic structure and essential content for a training session to educate vaccinators about hepatitis B, equip them with the skills to safely administer the hepatitis B vaccine, and prepare them to decrease drop-out rates and increase coverage through communication with parents, caretakers and local leaders.

This training module, developed by PATH, was developed to provide a basic structure and essential content for a training session to educate vaccinators about hepatitis B, equip them with the skills to safely administer the hepatitis B vaccine, and prepare them to decrease drop-out rates and increase coverage through communication with parents, caretakers and local leaders.

From 2008 to 2013, the Maternal and Child Health Integrated Program (MCHIP) provided in-depth technical assistance on the operational aspects of the introduction of 15 new vaccines in 10 GAVI-eligible countries; this represented 14% of all GAVI-supported introductions during this time period of vaccines used in routine immunization.

From 2008 to 2013, the Maternal and Child Health Integrated Program (MCHIP) provided in-depth technical assistance on the operational aspects of the introduction of 15 new vaccines in 10 GAVI-eligible countries; this represented 14% of all GAVI-supported introductions during this time period of vaccines used in routine immunization.

From 2008 to 2013, the Maternal and Child Health Integrated Program (MCHIP) provided in-depth technical assistance on the operational aspects of the introduction of 15 new vaccines in 10 GAVI-eligible countries; this represented 14% of all GAVI-supported introductions during this time period of vaccines used in routine immunization.

The Africa Routine Immunization Essentials (ARISE) project aimed to identify and document promising interventions leading to improved and sustained routine immunization system performance in sub-Saharan Africa. This document provides an overview of one common driver of improvements in routine immunization, namely the partnership between health systems and communities, and provides country-specific examples of how this partnership.